Advanced search
Publication Cover
Leukemia & Lymphoma Volume 48, 2007 - Issue 7
Submit an article Journal homepage
98
Views
5
CrossRef citations to date
0
Altmetric
Letter to the Editor

Salvage immuno-chemotherapy with a combination of rituximab, high-dose cytarabine, mitoxantrone and dexamethasone for patients with primary CNS lymphoma: A preliminary study

Ryuya Yamanaka Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan; Research Center of Innovative Cancer Therapy, Kurume University School of Medicine, Kurume, JapanCorrespondence[email protected]
, MD, PhD,
Junpei Homma Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan
,
Masakazu Sano Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan
,
Naoto Tsuchiya Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan
,
Naoki Yajima Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan
,
Hideaki Takahashi Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan
,
Yoshikatsu Shinbo Department of Neurosurgery, Itoigawa General Hospital, Itoigawa, Japan
,
Akira Hasegawa Department of Neurosurgery, Kobari Hospital, Niigata, Japan
,
Takashi Saitoh Department of Neurosurgery, Nagano Red Cross Hospital, Nagano, Japan
&
Ryuichi Tanaka Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan
 show all
Pages 1429-1433 | Received 12 Feb 2007, Accepted 26 Mar 2007, Published online: 01 Jul 2009

References

  • Abrey L E, Yahalom J, DeAngelis L M. Treatment for primary CNS lymphoma: the next step. J Clin Oncol 2000; 18: 3144–3150
  • O'Brien P, Roos D, Pratt G, Liew K, Barton M, Poulsen M, et al. Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma. J Clin Oncol 2000; 18: 519–526
  • Brada M, Hjiyiannakis D, Hines F, Traish D, Ashley S. Short intensive primary chemotherapy and radiotherapy in sporadic primary CNS lymphoma (PCL). Int J Radiat Oncol Biol Phys 1998; 40: 1157–1162
  • Poortmans P, Kluin-Nelemans H C, Haaxma-Reiche H, Van't Veer M, Hansen M, Soubeyran P, et al. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962. J Clin Oncol 2003; 21: 4483–4488
  • Reni M, Ferreri A J, Villa E. Second-line treatment for primary central nervous system lymphoma. Br J Cancer 1999; 79: 530–534
  • Cher L, Glass J, Harsh G R, Hochberg F H. Therapy of primary CNS lymphoma with methotrexate-based chemotherapy and deferred radiotherapy: preliminary results. Neurology 1996; 46: 1757–1759
  • Enting R H, Demopoulos A, DeAngelis L M, Abrey L E. Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide. Neurology 2004; 63: 901–903
  • Abrey L E, Moskowitz C H, Mason W P, Crump M, Stewart D, Forsyth P, et al. Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis. J Clin Oncol 2003; 21: 4151–4156
  • Coltman C A, Jr, Coltman T M, Balcerzak S P, Morrison F S, Von Hoff D D. Mitoxantrone in refractory non-Hodgkin's lymphoma. A Southwest Oncology Group study. Semin Oncol 1984; 11: 50–53
  • Yamanaka R, Morii K, Shinbo Y, Takeuchi S, Tamura T, Hondoh H, et al. Modified ProMACE-MOPP hybrid regimen with moderate dose methotrexate for patients with primary CNS lymphoma. Ann Hematol 2005; 84: 447–455
  • Yamanaka R, Homma J, Sano M, Tsuchiya N, Yajima N, Shinbo Y, et al. Immuo-chemotherapy with a combination of rituximab, methotrexate, pirarubicin and procarbazine for patients with primary CNS lymphoma – a preliminary report. Leuk Lymphoma, (in press)
  • Plotkin S R, Betensky R A, Hochberg F H, Grossman S A, Lesser G J, Nabors L B, et al. Treatment of relapsed central nervous system lymphoma with high-dose methotrexate. Clin Cancer Res 2004; 10: 5643–5646
  • Herrlinger U, Schabet M, Brugger W, Kortmann R D, Kuker W, Deckert M, et al. German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma. Ann Neurol 2002; 51: 247–252
  • Fischer L, Thiel E, Klasen H A, Birkmann J, Jahnke K, Martus P, et al. Prospective trial on topotecan salvage therapy in primary CNS lymphoma. Ann Oncol 2006; 17: 1141–1145
  • Reni M, Mason W, Zaja F, Perry J, Franceschi E, Bernardi D, et al. Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trial. Eur J Cancer 2004; 40: 1682–1688

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.